Science

Immune Checkpoint Combinations in mCRPC, by Dr. Susan Slovin

Susan F. Slovin/mskcc.org

Mar 24, 2025, 10:41

Immune Checkpoint Combinations in mCRPC, by Dr. Susan Slovin

Ravi A Madan, Clinical researcher at the National Cancer Institute, shared an article by Susan F. Slovin, et al. on X:

“Dr. Susan Slovin Memorial Sloan Kettering Cancer Center asks some key questions regarding Prostate Cancer.

Immune Checkpoint Combos in mCRPC: Where Are We Going, What Are We Doing, and Why?”

Immune Checkpoint Combos in Metastatic Castration-Resistant Prostate Cancer: Where Are We Going, What Are We Doing, and Why?

Authors: Susan F. Slovin, et al.

Immune Checkpoint Combinations in mCRPC, by Dr. Susan Slovin

cancer fight against cancer Global fight against cancer Immune Checkpoint mCRPC Memorial Sloan Kettering Cancer Center metastatic castration-resistant prostate cancer National Cancer Institute NCI OncoDaily Oncology prostate cancer Ravi A. Madan Susan F. Slovin

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Paolo Tarantino: AACR Journals' Power Move for Reviewers

Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership

Mohit Manrao: FDA Grants Priority Review for sBLA in Resectable Early-Stage Gastric and GEJ Cancers